Skip to main content
    F

    Fortrea Holdings Inc. (FTRE)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $19.79
    -0.41 (-2.03%)

    Market Cap: $1.95B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Fortrea Holdings Inc. (FTRE) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Fortrea Holdings (FTRE) trades at 26.0x trailing earnings and 0.7x sales. Its forward P/E is 10.6x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 145.3% higher over the next year. Its free cash flow yield is 8.8%.

    MultipleValue
    P/E (trailing)26.0x
    Forward P/E10.6x
    Price to sales0.7x
    Price to book3.6x
    EV/EBITDA25.5x
    Price to FCF11.3x
    EV/FCF16.2x
    PEG0.3
    FCF yield8.8%
    As of Nov 17, 2026

    Valuation History

    Over the 3 year ends shown, its P/E ranged from 24.9x in 2023 to 54.9x in 2024.

    Year endPriceP/EP/SP/B
    2025$17.2541.1x0.6x2.8x
    2024$18.6554.9x0.6x1.2x
    2023$34.9024.9x1.1x1.8x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About FTRE

    What is FTRE's forward P/E ratio?

    Fortrea Holdings has a forward P/E ratio of 10.6x.

    Is FTRE stock overvalued?

    GNG's valuation label for FTRE is Fairly valued.

    What is FTRE's price to sales ratio?

    Fortrea Holdings has a price to sales ratio of 0.7x.

    What is FTRE's PEG ratio?

    Fortrea Holdings has a PEG ratio of 0.3.